Swissprot No Q15021 Gene Accession BC028182 WB Predicted band size 157 kDa WB Positive control WB Recommended dilution 1000-5000 IHC predicted cell location Predicted cell location: Cytoplasm and Nucleus IHC positive control Positive control: Human gastric cancer IHC Recommed dilution Recommended dilution: 50-200 Storage
Swissprot No Q07812 Gene Accession BC014175 WB Predicted band size 21 kDa WB Positive control WB Recommended dilution 5000-20000 IHC predicted cell location Predicted cell location: Cytoplasm IHC positive control Positive control: Human cervical cancer IHC Recommed dilution Recommended dilution: 50-200 Storage
researchers can better understand their intricate roles and potential as therapeutic targets
Recommended Reaction Conditions
Model Numner H100-Pro Functions Heating Temperature range Heating: room temp+5℃- 100°C Temperature setting range 15-100℃ Temperature control accuracy ±0
B-Raf inhibitor 1 Size:25mg Swissprot No Q15021 Gene AccessionDescription B Raf inhibitor 1 (Compound 13) is a type IIA Raf inhibitor which bind to the DFG out conformation with ki of 1 nM,1 nM,and 0. 3 nM for B Raf(WT), B Raf(V600E) and C Raf, respectively. For research use only. We do not sell to patients. Specification Formal Name N1 (4 chlorophenyl) 6 methyl N5 [3 (9H purin 6 yl) 2 pyridinyl] 1,5 isoquinolinediamine, dihydrochloride CAS Number 1191385 19 9 Molecular Formula C26H19ClN8 2HCl Formula Weight